1. Pentyl Gallate Nanoemulsions as Potential Topical Treatment of Herpes Labialis
- Author
-
Sávia Caldeira de Araújo Lopes, Morgana Pistore, Letícia Scherer Koester, Ricardo José Nunes, Caroline Rigotto, Mariana Colombo, Izabella Thaís Silva, Cláudia Maria Oliveira Simões, Regina G. Kelmann, Helder Ferreira Teixeira, Silvane Souza Roman, and Daniele Dall Agnol
- Subjects
Male ,Swine ,Stereochemistry ,Administration, Topical ,Skin Absorption ,Pharmaceutical Science ,Topical treatment ,Herpesvirus 1, Human ,02 engineering and technology ,Pharmacology ,Virus Replication ,medicine.disease_cause ,Antiviral Agents ,Skin Diseases ,030226 pharmacology & pharmacy ,Dosage form ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Drug Stability ,Dermis ,Gallic Acid ,medicine ,Animals ,Distribution (pharmacology) ,Gallic acid ,Rats, Wistar ,Herpes Labialis ,021001 nanoscience & nanotechnology ,Rats ,Herpes simplex virus ,medicine.anatomical_structure ,Solubility ,chemistry ,Toxicity ,Irritants ,Emulsions ,0210 nano-technology - Abstract
Previous studies have demonstrated the antiherpes activity of pentyl gallate (PG), suggesting that it could be a promising candidate for the topical treatment of human herpes labialis. PG low aqueous solubility represents a major drawback to its incorporation in topical dosage forms. Hence, the feasibility of incorporating PG into nanoemulsions, the ability to penetrate the skin, to inhibit herpes simplex virus (HSV)-1 replication, and to cause dermal sensitization or toxicity were evaluated. Oil/water nanoemulsions containing 0.5% PG were prepared by spontaneous emulsification. The in vitro PG distribution into porcine ear skin after topical application of nanoemulsions was assessed, and the in vitro antiviral activity against HSV-1 replication was evaluated. Acute dermal toxicity and risk of dermal sensitization were evaluated in rat model. Nanoemulsions presented nanometric particle size (from 124.8 to 143.7 nm), high zeta potential (from -50.1 to -66.1 mV), loading efficiency above 99%, and adequate stability during 12 months. All formulations presented anti-HSV-1 activity. PG was able to reach deeper into the dermis more efficiently from the nanoemulsion F4. This formulation as well as PG were considered safe for topical use. Nanoemulsions seem to be a safe and effective approach for topically delivering PG in the treatment of human herpes labialis infection.
- Published
- 2016
- Full Text
- View/download PDF